Evaluation of an Intensified Systematic Screening for Congenital Hypothyroidism in Premature Newborns
Key facts
- Where
- Lille, FranceSee the site
Where in France
- CHU de LilleLille, FranceContact: Christine LEFEVRE, MDNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital, Lille
- Trial code
- NCT07425028
- Record updated
- 22 May 2026
- Original description
Currently in France, screening for congenital hypothyroidism (CH) in premature infants is done by a single TSH assay on filter paper. However, European recommendations advise repeating the assay within the first month of life.Read full original descriptionShow less
Currently in France, screening for congenital hypothyroidism (CH) in premature infants is done by a single TSH assay on filter paper. However, European recommendations advise repeating the assay within the first month of life.
Our primary objective is to estimate the incidence of CH in preterm infants under 32 weeks of gestational age by applying the European recommendations.
Inclusion: Newborns born prematurely between 23 and 32 weeks of gestational age (up to 31 weeks and 6 days), both female and male, of all ethnic origins, regardless of birth weight, and including all other pathologies; Newborns whose parents have given their non-opposition consent.
Exclusion: Newborns who die before 15 days of age; Newborns born who leave the region before day 15; Newborns whose parents are not affiliated with the social security system.